Primary Care Intervention Aids Patient Follow-Up for Abnormal Cancer Screening
Primary care clinicians take a “whole person” approach and are responsible for a wide range of preventive healthcare efforts....
Primary care clinicians take a “whole person” approach and are responsible for a wide range of preventive healthcare efforts....
This study has two objectives: first, to explore the diagnostic experiences of black/African American (BAA) patients with lung cancer to pinpoint pitfalls, suboptimal experiences and instanc...
Bookmark Click to read this study in NEJM. VA design by Bryan Sun. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 ...
Selpercatinib doubled progression-free survival, increased response rate, and delayed pulmonary and physical deterioration in RET fusion-positive NSCLC....
Toripalimab added to etoposide plus cisplatin or carboplatin improved survival in extensive-stage small cell lung cancer....
Perioperative chemotherapy plus nivolumab outperforms perioperative chemotherapy alone in patients with resectable non-small cell lung cancer....
The objective of this study was to describe the patterns of failure (POF), frequency of low volume relapse (LVR), and candidacy for further ablative therapy at time of disease progression (P...
The intricate molecular pathways governing cancer development and progression have spurred intensive investigations into novel therapeutic targets. Glycogen Synthase Kinase-3 (GSK3), a compl...
Bookmark1. 4-year event-free survival was significantly greater in I-SABR (77%) versus SABR alone (53%). 2. More patients in the I-SABR group experienced grade 3 immunological adverse events...
Local consolidative therapy (LCT) has emerged as a promising approach for the treatment of oligometastatic non-small cell lung cancer (NSCLC). While stage IV NSCLC was traditionally consider...
The rhythmic expression of the circadian clock is intimately linked to the health status of the body. Disturbed circadian clock rhythms might lead to a wide range of metabolic diseases and e...
A real-world study confirms survival outcomes of atezolizumab plus chemotherapy in extensive-stage small cell lung cancer....
Epigenetic alterations are widespread in cancer and can complement genetic alterations to influence cancer progression and treatment outcome. To determine the potential contribution of DNA m...
Cancer cachexia is a systemic inflammation-driven syndrome, characterized by muscle atrophy and adipose tissue wasting, with progressive weight loss leading to serious impairment of physiolo...
Lung adenocarcinoma (LUAD) is a common subtype of primary lung cancer. Fatty acid oxidation plays a key role in LUAD development by providing energy for tumor cells. This study aimed to iden...
This study compares the bioactivity of six sulfated polysaccharides derived from glucose- and sucrose-feeding extracted from P. cocos. Anti-inflammatory potentials of these polysaccharides w...
Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) is important for the expression of genes associated with oxidative stress. The levels of NRF2 are controlled by Kelch-like ECH-associated p...
Lung cancer maintains a high morbidity and mortality rate globally despite significant advancements in detection and therapy in the era of precision medicine. Excisional biopsy and histopath...
A tumor, node, metastases (TNM)-based stage classification system of thymic epithelial tumors was adopted for the 8 edition of the stage classification of malignant tumors. The Thymic Domain...
Bookmark1. Median overall survival in the atezolizumab group was 10.3 months versus 9.2 months in the chemotherapy group. 2. Patients assigned to atezolizumab had fewer treatment-related adv...
The latest articles and insights from your colleagues in your specialty(ies) of choice.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.